PMID- 37789894 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231030 IS - 1664-2295 (Print) IS - 1664-2295 (Electronic) IS - 1664-2295 (Linking) VI - 14 DP - 2023 TI - A milder form of molybdenum cofactor deficiency type A presenting as Leigh's syndrome-like phenotype highlighting the secondary mitochondrial dysfunction: a case report. PG - 1214137 LID - 10.3389/fneur.2023.1214137 [doi] LID - 1214137 AB - BACKGROUND: Molybdenum cofactor deficiency (MoCD) (OMIM# 252150) is an autosomal-recessive disorder caused by mutations in four genes involved in the molybdenum cofactor (MOCO) biosynthesis pathway. OBJECTIVES: We report a milder phenotype in a patient with MOCS1 gene mutation who presented with a Leigh-like presentation. CASE REPORT: We present the case of a 10-year-old boy who was symptomatic at the age of 5 months with sudden onset of dyskinesia, nystagmus, and extrapyramidal signs following a febrile illness. Initial biochemical, radiological, and histopathological findings a Leigh syndrome-like phenotype; however, whole-exome sequencing detected compound heterozygous mutations in MOCS1 gene, c.1133 G>C and c.217C>T, confirming an underlying MoCD. This was biochemically supported by low uric acid level of 80 (110-282 mmol/L) and low cystine level of 0 (3-49), and a urine S-sulfocysteine at 116 (0-15) mmol/mol creatinine. The patient was administered methionine- and cystine-free formulas. The patient has remained stable, with residual intellectual, speech, and motor sequelae. CONCLUSION: This presentation expands the phenotypic variability of late-onset MoCD A and highlights the role of secondary mitochondrial dysfunction in its pathogenesis. CI - Copyright (c) 2023 Almudhry, Prasad, Rupar, Tay, Ratko, Jenkins and Prasad. FAU - Almudhry, Montaha AU - Almudhry M AD - London Health Sciences Centre, London, ON, Canada. AD - Department of Neuroscience, King Fahad Specialist Hospital, Dammam, Saudi Arabia. FAU - Prasad, Asuri N AU - Prasad AN AD - London Health Sciences Centre, London, ON, Canada. AD - Department of Pediatrics, Western University, London, ON, Canada. AD - Department of Clinical Neurological Sciences, Western University, London, ON, Canada. FAU - Rupar, C Anthony AU - Rupar CA AD - London Health Sciences Centre, London, ON, Canada. AD - Department of Pediatrics, Western University, London, ON, Canada. AD - Department of Biochemistry, Western University, London, ON, Canada. FAU - Tay, Keng Yeow AU - Tay KY AD - London Health Sciences Centre, London, ON, Canada. AD - Department of Medical Imaging, Western University, London, ON, Canada. FAU - Ratko, Suzanne AU - Ratko S AD - London Health Sciences Centre, London, ON, Canada. FAU - Jenkins, Mary E AU - Jenkins ME AD - London Health Sciences Centre, London, ON, Canada. AD - Department of Clinical Neurological Sciences, Western University, London, ON, Canada. FAU - Prasad, Chitra AU - Prasad C AD - London Health Sciences Centre, London, ON, Canada. AD - Department of Pediatrics, Western University, London, ON, Canada. LA - eng PT - Case Reports DEP - 20230915 PL - Switzerland TA - Front Neurol JT - Frontiers in neurology JID - 101546899 PMC - PMC10542394 OTO - NOTNLM OT - Leigh-like phenotype OT - MOCS1 OT - dystonia OT - molybdenum cofactor deficiency OT - stroke COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/10/04 06:43 MHDA- 2023/10/04 06:44 PMCR- 2023/09/15 CRDT- 2023/10/04 03:55 PHST- 2023/04/29 00:00 [received] PHST- 2023/08/18 00:00 [accepted] PHST- 2023/10/04 06:44 [medline] PHST- 2023/10/04 06:43 [pubmed] PHST- 2023/10/04 03:55 [entrez] PHST- 2023/09/15 00:00 [pmc-release] AID - 10.3389/fneur.2023.1214137 [doi] PST - epublish SO - Front Neurol. 2023 Sep 15;14:1214137. doi: 10.3389/fneur.2023.1214137. eCollection 2023.